Although the application of particular ART in humans is still highly experimental, tightly regulated, and surrounded by ethical and legal challenges, certain ART methods are already widely available. While established techniques such as in vitro fertilization (IVF), cryopreservation, egg and sperm donation, and surrogacy are widely used to address infertility and help individuals or couples conceive, emerging technologies are expanding the boundaries of what is possible. Some examples include: (i) time-lapse imaging -advanced embryo monitoring systems improving the selection of viable embryos for transfer; (ii) preimplantation genetic testing screening embryos for chromosomal abnormalities or inherited conditions, reducing the risk of miscarriage and genetic disorders; (iii) in-vitro maturation enables immature eggs to mature outside the body, providing an alternative for patients who cannot undergo traditional stimulation protocols; (iv) laser-assisted hatching technique helps embryos implant by softening the protective shell (zona pellucida), which can sometimes hinder implantation in older women or those using frozen embryos; (v) AI is enhancing embryo selection, predicting treatment outcomes, and customizing patient protocols; machine learning models analyze patient data to predict the probability of successful pregnancy, tailoring treatment protocols accordingly. Success rates for ART vary based on factors like age, the cause of infertility, and the type of procedure. Advanced techniques like genetic testing and AI are helping to improve outcomes. Notable recent patents ART-related patents in CAS Content Collection grow not only in numbers but also in formulation and methodology diversity. Summarized in Table are notable recent patents related to ART, illustrating their diversity.